LATEST ALERTS
Canopy Growth will stop producing its own cannabis beverages, edibles, vapes and extracts as it continues to look at ways to increase profitability. Using a third-party sourcing model for these products will allow it to free up funds
This report provides an overview of the current regulatory framework in place in South Africa for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
France has started a process that could end with a Europe-wide ban on CBD-containing cosmetic products if an EU assessment finds them not safe for consumers’ reproductive health
British American Tobacco (BAT) will petition Belgium’s highest administrative court, the Council of State, to annul a royal decree banning the sale of cannabinoid pouches, along with those containing nicotine
The Czech government is still knee deep in trying to create a recreational cannabis market, but it looks like tightening up enforcement on tangential areas is no longer as much of a concern
This report provides a detailed analysis of the regulatory framework in place in the European Union for cannabis, hemp, CBD and other cannabinoids – intoxicating or not – covering all policy areas
Legal recreational cannabis sales for adult use are expected to begin next year in Minnesota following agreement on a bill between the state’s House and Senate
The Czech government will no longer go forward with a proposed measure to ban sales of food products containing CBD which was due to come into effect in mid-June
The Czech Republic has taken another interesting U-turn, announcing then almost at once retracting a ban on CBD foods – but what might it all mean for recreational cannabis, or IHDCs?
CannIntelligence has analysed regulations and contacted authorities in the majority of European countries to determine the legality of IHDCs. This report presents our findings
This report offers a detailed analysis of the online retail landscape for IHDCs, highlighting the top online retailers, traffic analysis of their websites, and the various types and formats available on the European market
The UK government’s plan to review or revoke thousands of pieces of legislation that originated from EU law by the end of the year is itself now under review
US-based 22nd Century reported record cannabinoid ingredient volumes delivered in the first quarter of 2023 and expects those to increase further throughout the year
The Czech Republic is to start taking action against ingestible cannabinoid products in a move believed to be part of a general tightening of enforcement of current regulations
This report provides an estimate of the market size of delta-8 THC in the US for 2023, and breakdowns by form factor and geographical regions, as well as scenarios for possible future growth
Kombinat Konopny CEO and founder Maciej Kowalski talks to podcast host Oliver Prescott about the company’s win in Poland’s high court, subsequent changes in the industry and current cannabis food policy in Europe
Twitter has claimed to have made another “major” step forward in cannabis advertising. But again the devil is in the details, which remain vague and contradictory
Mexican president Andrés Manuel López Obrador alleged that cannabis permits awarded to companies linked to former president Vicente Fox in 2018 involved influence peddling and corruption
Avicanna in Toronto reported total fiscal 2022 revenue up 24% from fiscal 2021, while in Pennsylvania, Zynerba Pharmaceuticals reduced its net loss last year by over $2m
This report highlights key findings from a consumer survey conducted by CannIntelligence on the usage and perception of delta-8 THC in the US
This report provides a detailed overview of Latvia’s regulatory framework for CBD and cannabis, as well as other minor cannabinoids, covering all policy areas
The Ministry of Health in the Czech Republic has unveiled plans to ban the sale of hexahydrocannabinol (HHC) this July, triggering criticism from local industry insiders
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
